Ligand Pharmaceuticals Inc (LGND) Cost of Revenue & History | Stock Alarm

Demo Sign up Log In

Ligand Pharmaceuticals Inc · Cost of Revenue

LGND Cost of Revenue

Latest reported$4.12Mperiod endingJun 30, 2026

LGND Cost of Revenue ($24.70M → $4.12M)

Annual cost of revenue

High-resolution chart · PNG

LGND cost of revenue history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ligand Pharmaceuticals Inc Cost of Revenue — Annual fiscal periods (USD)
Period ending	Cost of Revenue (USD)
Dec 31, 2025	6,587,500
Dec 31, 2024	11,074,000
Dec 31, 2023	35,049,000
Dec 31, 2022	52,827,000
Dec 31, 2021	62,176,000
Dec 31, 2020	30,419,000
Dec 31, 2019	11,347,000
Dec 31, 2018	6,337,000
Dec 31, 2017	5,366,000
Dec 31, 2016	5,571,000
Dec 31, 2015	5,807,000
Dec 31, 2014	9,136,000
Dec 31, 2013	5,733,000
Dec 31, 2012	3,601,000
Dec 31, 2011	4,909,000
Dec 31, 2010	0
Dec 31, 2009	15,235,000
Dec 31, 2008	0
Dec 31, 2007	0
Dec 31, 2006	22,642,000
Dec 31, 2005	39,847,000
Dec 31, 2004	39,804,000
Dec 31, 2003	31,618,000
Dec 31, 2002	20,306,000
Dec 31, 2001	13,947,000
Dec 31, 2000	1,618,000
Dec 31, 1999	3,100,000
Dec 31, 1998	-7,700,000
Dec 31, 1997	-9,800,000
Dec 31, 1996	-9,400,000
Dec 31, 1995	-3,700,000
Dec 31, 1994	24,700,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.